Welcome to our dedicated page for Expion360 SEC filings (Ticker: XPON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Expion360 Inc. (XPON) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret complex documents. As a Nasdaq-listed manufacturer of premium lithium iron phosphate (LiFePO4) batteries and accessories for RV, marine, Light EV and residential energy storage markets, Expion360 uses its SEC filings to report on financial performance, capital structure, governance, and material agreements.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q to see detailed discussions of revenue, cost of sales, gross margin, operating expenses, cash flows, and balance sheet items. These reports also describe the company’s business focus on LiFePO4 batteries and accessories, its distribution network of dealers, wholesalers, private-label customers, and OEMs, and its efforts to develop home energy storage and other energy storage applications.
Expion360 files frequent Current Reports on Form 8-K to disclose material events. Recent 8-Ks have covered topics such as warrant inducement transactions and exercise price reductions, private placements and registered offerings, the establishment of an at-the-market issuance sales agreement, leadership changes including the appointment of a new Chief Executive Officer and Chief Financial Officer, and confirmations of regained compliance with Nasdaq listing rules related to minimum bid price and stockholders’ equity.
Through SEC filings, investors can also track equity and warrant activity, including changes in outstanding shares, warrant terms, and the impact of warrant exercises on cash, liabilities, and stockholders’ equity. Proxy-related filings and meeting results provide insight into stockholder votes on items such as board elections and equity incentive plans.
Stock Titan enhances this information by offering AI-powered summaries that highlight key points from lengthy 10-K, 10-Q, and 8-K filings, helping readers quickly identify changes in financial condition, capital-raising transactions, and governance developments. Real-time updates from EDGAR ensure that new filings, including any Form 4 insider transaction reports or future registration statements, are incorporated promptly so users can monitor how Expion360 manages its LiFePO4 battery and energy storage business from a regulatory and financial reporting perspective.
Expion360 Inc. announced that Brian Schaffner has resigned from his additional role as Interim Chief Financial Officer and will continue to serve solely as Chief Executive Officer and a member of the board. The board appointed Shawna Bowin, previously the Company’s Controller, as Chief Financial Officer and principal financial officer, effective September 3, 2025.
Bowin has over 20 years of accounting experience and joined Expion360 in 2022, becoming Controller in February 2025. Under a new employment agreement effective September 3, 2025, she will receive a base salary of $192,000, a one-time bonus of $192,000 tied to her appointment and prior performance, and eligibility for annual bonuses and participation in the Company’s benefit and incentive plans. The agreement also includes indemnification and standard restrictive covenants such as one-year non-compete, non-solicitation, non-disparagement, and confidentiality provisions.
Expion360 Inc. reported that holders exercised a total of 4,878,942 warrants (4,279,749 Series A Warrants and 599,193 January Warrants), resulting in issuance of 4,878,942 shares of common stock and net cash proceeds of approximately $5.65 million after fees and expenses. The company states the previously recorded "Reverse Stock Split Cash True-up Payment" liability tied to Section 3.8 of the Series A Warrants is no longer payable.
Following these exercises, 1,006,943 Series A Warrants remain outstanding with a $1.31 exercise price exercisable through September 30, 2029, and 449,193 January Warrants remain outstanding with a $1.31 exercise price exercisable through January 3, 2030. The filing includes unaudited pro forma balance sheet information adjusted as if the warrant adjustments occurred on June 30, 2025; the company notes these estimates have not been reviewed by its independent auditors and are for informational purposes only.
Expion360 Inc. entered into an inducement offer letter with the holders of a substantial majority of its August Series A warrants and all holders of its January warrants. In this agreement, the company reduced the exercise price of the August Series A Warrants from $5.206 per share to $1.31 per share and the January Warrants from $2.36 per share to $1.31 per share in exchange for the simultaneous exercise of these warrants.
The August Series A Warrants, issued on August 8, 2024 and exercisable until September 30, 2029, and the January Warrants, issued on January 3, 2025 and exercisable until January 3, 2030, both relate to shares of common stock that have already been registered for resale on effective Form S-1 registration statements. The filing also notes that the inducement letter includes customary representations, warranties, and covenants between Expion360 and the warrant holders.
Expion360 reported meaningful sales growth but remains loss-making with material liquidity and listing risks. Net sales rose to $2.99 million for the three months ended June 30, 2025, up 134% from $1.28 million a year earlier, and to $5.04 million for the six months, up 124% versus 2024. Gross profit improved, and net loss narrowed to $1.37 million for the quarter (a 38% improvement) and $2.52 million for six months (a 43% improvement). Cash and cash equivalents were $684,920 at June 30, 2025, and the company carried an accumulated deficit of $37.1 million. Management disclosed substantial doubt about the company’s ability to continue as a going concern. The company completed a January 2025 public offering that generated $2.60 million gross ($1.78 million net) and used $500,000 toward a suspended reverse-split cash true-up, leaving a suspended liability of $4.49 million. Customer concentration remains high (two customers = ~53% of quarterly sales). On July 1, 2025 Nasdaq staff determined the company failed the $1.00 minimum bid price rule and initiated delisting proceedings; a hearing is scheduled for August 19, 2025.
Expion360 Inc. announced that it furnished a press release and investor presentation reporting financial results for the fiscal quarter ended June 30, 2025 and will host a conference call to discuss those results.
The company confirmed it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed above $1.00 for the required period, so its shares remain listed and traded on The Nasdaq Capital Market; a previously scheduled appeal hearing was cancelled.
Expion360 (XPON) Form 4 filed 1-Aug-25 details insider equity awards to director Tien Q. Nguyen. On 31-Jul-25 Nguyen received 5,000 restricted stock units that vested immediately; each RSU converts into one common share at no cost. The filing also discloses a simultaneous grant of 5,000 stock options exercisable at $0.9329, the board-approved closing price. The options vested in full on the grant date and expire 31-Jul-35.
Post-transaction, the director’s beneficial ownership totals 10,122 shares/equivalents: 122 shares held outright, 5,000 vested RSUs and 5,000 option shares exercisable within 60 days. No dispositions or cash purchases occurred.
The grants were enabled by shareholder approval of an increase in shares available under the 2021 Incentive Award Plan. While the aggregate 10,000 new rights are modest versus XPON’s float, they signal tighter director-company alignment and introduce a small potential dilution over time.